학술논문
Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study
Document Type
Article
Author
Source
In: Frontiers in Neurology . (Frontiers in Neurology, 9 May 2022, 13)
Subject
Language
English
ISSN
16642295